[DOI] [PubMed] [Google Scholar] 21.Keremi B, Lohinai Z, Komora P, Duhaj S, Borsi K, Jobbagy-Ovari G, et al
This product is sold exclusively for research and educational purposes
3-Month Protocol: $445 $148/mo save $80 6-Month Protocol: $840 $140/mo save $210 The $175/month fee includes the pharmaceutical-grade compound from a licensed compounding pharmacy, medical oversight, and ongoing access to your provider for protocol adjustments
The Medicinal-Chemistry Disclosure (2021) The primary design paper describing cagrilintide was published by Andreassen and colleagues in the Journal of Medicinal Chemistry in 2021 [1]
A healthcare professional can administer these injections
Increased clearance of IgG in mice that lack beta(2)-microglobulin: possible protective role of FcRn